EV/EBITDA
-16.66
0.000.00%
Fri, 21 Feb 2025 23:27:44 GMT
Summary
- As of February 22, 2025, APLS EV/EBITDA is -16.66, unchanged from the previous trading day.
- Over the past year, APLS EV/EBITDA has dropped by -0.95 (-6.05%).
- APLS EV/EBITDA is now -364.07% below its all-time high of -3.59.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +8.6% | -8.6% | -8.7% |
| 3 m3 months | +0.8% | -0.7% | -0.8% |
| 6 m6 months | +2.1% | -31.2% | -32.5% |
| ytdytd | +15.5% | -15.5% | -15.8% |
| 1 y1 year | -6.0% | -55.1% | -58.6% |
| 5 y5 years | -92.8% | +35.3% | -25.4% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.4% | -18.64 | +10.6% | |
| 3 m | 3-month | -16.60 | -0.4% | -21.58 | +22.8% |
| 6 m | 6-month | -12.45 | -33.8% | -21.58 | +22.8% |
| 1 y | 1-year | -11.35 | -46.8% | -21.58 | +22.8% |
| 3 y | 3-year | -3.59 | -364.1% | -21.58 | +22.8% |
| 5 y | 5-year | -3.59 | -364.1% | -21.58 | +22.8% |
| alltime | all time | -3.59 | -364.1% | -27.46 | +39.3% |
Apellis Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.66(-15.5%) |
| 2024 | -19.72(+41.2%) |
| 2023 | -13.97(+63.0%) |
| 2022 | -8.57(+49.8%) |
| Date | Value |
|---|---|
| 2021 | -5.72(-57.1%) |
| 2020 | -13.34(+126.1%) |
| 2019 | -5.90(+23.7%) |
| 2018 | -4.77(-74.4%) |
| 2017 | -18.62 |
FAQ
- What is Apellis Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of APLS is -16.66
What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high EV/EBITDA is -3.59
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals EV/EBITDA has changed by +3.06 (+15.52%) since the beginning of the year
What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -0.95 (-6.05%)